Stefano Martellucci

29PUBLICATIONS
35CO-AUTHORS
Neurology and neuromuscular diseasesMolecular targetsMolecular medicineSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 23, 2026
Cellular prion protein and its derived peptides: multifaceted roles in neurodegenerative diseases and potential as biomarkers.

|Dec 31, 2025
RETRACTED: Gravina et al. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. Cancers 2019, 11, 1604.

Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro

|Dec 31, 2025
RETRACTED: Gravina et al. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models. Cancers 2019, 11, 359.

Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro

|Dec 22, 2025
Schwann cell Lrp1 deletion drives trigeminal neuron sensitization and orofacial pain by modulating mitochondrial function and TRPV1/TRPA1 activity.

Zhiting Gong, Morgan Zhang, Naijiang Liu

|Aug 29, 2024
Correction: Gravina et al. ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma. Cancers 2022, 14, 289.

Giovanni Luca Gravina, Alessandro Colapietro, Andrea Mancini

|Feb 19, 2024
Axon-derived PACSIN1 binds to the Schwann cell survival receptor, LRP1, and transactivates TrkC to promote gliatrophic activities.

Stefano Martellucci, Andreas Flütsch, Mark Carter

Pageof 5

Frequent Collaborators

22 joint publications

Vincenzo Mattei

8 joint publications

Simona Delle Monache

8 joint publications

Claudio Festuccia

6 joint publications

Adriano Angelucci